LeMaitre Vascular, Inc. (LMAT): Price and Financial Metrics


LeMaitre Vascular, Inc. (LMAT): $54.89

-0.27 (-0.49%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

LMAT POWR Grades


  • Quality is the dimension where LMAT ranks best; there it ranks ahead of 79.94% of US stocks.
  • LMAT's strongest trending metric is Stability; it's been moving up over the last 52 weeks.
  • LMAT ranks lowest in Momentum; there it ranks in the 33rd percentile.

LMAT Stock Summary

  • The price/operating cash flow metric for Lemaitre Vascular Inc is higher than 78.88% of stocks in our set with a positive cash flow.
  • With a year-over-year growth in debt of -51.45%, Lemaitre Vascular Inc's debt growth rate surpasses just 9.06% of about US stocks.
  • In terms of twelve month growth in earnings before interest and taxes, Lemaitre Vascular Inc is reporting a growth rate of 91.04%; that's higher than 78.8% of US stocks.
  • If you're looking for stocks that are quantitatively similar to Lemaitre Vascular Inc, a group of peers worth examining would be NBRV, SSD, ISR, ATRI, and EFOI.
  • LMAT's SEC filings can be seen here. And to visit Lemaitre Vascular Inc's official web site, go to www.lemaitre.com.

LMAT Valuation Summary

  • LMAT's price/sales ratio is 8.1; this is 28.63% lower than that of the median Healthcare stock.
  • LMAT's price/sales ratio has moved up 5.2 over the prior 181 months.
  • Over the past 181 months, LMAT's price/earnings ratio has gone up 256.6.

Below are key valuation metrics over time for LMAT.

Stock Date P/S P/B P/E EV/EBIT
LMAT 2021-08-31 8.1 6.6 42.6 32.3
LMAT 2021-08-30 8.2 6.6 42.7 32.3
LMAT 2021-08-27 8.1 6.6 42.4 32.1
LMAT 2021-08-26 7.8 6.3 40.9 31.0
LMAT 2021-08-25 7.9 6.4 41.1 31.1
LMAT 2021-08-24 7.9 6.4 41.5 31.4

LMAT Growth Metrics

  • Its 2 year cash and equivalents growth rate is now at -51.96%.
  • Its 3 year price growth rate is now at 73.67%.
  • Its year over year cash and equivalents growth rate is now at 114.96%.
Over the past 33 months, LMAT's revenue has gone up $47,185,000.

The table below shows LMAT's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2021-06-30 150.517 44.235 28.774
2021-03-31 134.698 39.685 23.975
2020-12-31 129.366 34.8 21.22
2020-09-30 121.988 26.242 18.8
2020-06-30 114.672 16.6 16.471
2020-03-31 119.304 15.587 17.595

LMAT's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • LMAT has a Quality Grade of B, ranking ahead of 79.94% of graded US stocks.
  • LMAT's asset turnover comes in at 0.597 -- ranking 73rd of 186 Medical Equipment stocks.
  • OFIX, SRTS, and SSKN are the stocks whose asset turnover ratios are most correlated with LMAT.

The table below shows LMAT's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-06-30 0.597 0.649 0.299
2021-03-31 0.530 0.653 0.241
2020-12-31 0.542 0.654 0.220
2020-09-30 0.548 0.657 0.196
2020-06-30 0.574 0.677 0.177
2020-03-31 0.676 0.678 0.210

LMAT Price Target

For more insight on analysts targets of LMAT, see our LMAT price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $66.14 Average Broker Recommendation 1.5 (Moderate Buy)

LMAT Stock Price Chart Interactive Chart >

Price chart for LMAT

LMAT Price/Volume Stats

Current price $54.89 52-week high $64.50
Prev. close $55.16 52-week low $32.30
Day low $54.26 Volume 68,800
Day high $55.36 Avg. volume 125,599
50-day MA $55.35 Dividend yield 0.8%
200-day MA $52.69 Market Cap 1.19B

LeMaitre Vascular, Inc. (LMAT) Company Bio


LeMaitre Vascular is a provider of devices and implants for the treatment of peripheral vascular disease. The company was founded in 1983 and is based in Burlington, Massachusetts.


LMAT Latest News Stream


Event/Time News Detail
Loading, please wait...

LMAT Latest Social Stream


Loading social stream, please wait...

View Full LMAT Social Stream

Latest LMAT News From Around the Web

Below are the latest news stories about Lemaitre Vascular Inc that investors may wish to consider to help them evaluate LMAT as an investment opportunity.

LeMaitre Vascular, Inc. (NASDAQ:LMAT) Stake Lowered by Dimensional Fund Advisors LP

Dimensional Fund Advisors LP cut its stake in shares of LeMaitre Vascular, Inc. (NASDAQ:LMAT) by 1.1% in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 691,722 shares of the medical instruments suppliers stock after selling 7,842 shares during the quarter. Dimensional Fund Advisors []

Dakota Financial News | October 21, 2021

Analysts Estimate LeMaitre Vascular (LMAT) to Report a Decline in Earnings: What to Look Out for

LeMaitre (LMAT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Yahoo | October 21, 2021

LeMaitre Vascular (NASDAQ:LMAT) shareholders have earned a 24% CAGR over the last five years

The worst result, after buying shares in a company (assuming no leverage), would be if you lose all the money you put...

Yahoo | October 20, 2021

$39.38 Million in Sales Expected for LeMaitre Vascular, Inc. (NASDAQ:LMAT) This Quarter

Wall Street analysts expect LeMaitre Vascular, Inc. (NASDAQ:LMAT) to report $39.38 million in sales for the current quarter, Zacks reports. Five analysts have issued estimates for LeMaitre Vasculars earnings, with the lowest sales estimate coming in at $38.60 million and the highest estimate coming in at $40.15 million. LeMaitre Vascular posted sales of $36.42 million []

Transcript Daily | October 19, 2021

LeMaitre Will Announce Third Quarter 2021 Earnings Results on October 28, 2021

BURLINGTON, Mass., Oct. 14, 2021 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will release its third quarter 2021 financial results on Thursday, October 28, 2021, after the market close. The company has scheduled a conference call for 5:00 PM ET the same day to discuss the results, business highlights, and company outlook.

Intrado Digital Media | October 14, 2021

Read More 'LMAT' Stories Here

LMAT Price Returns

1-mo 0.27%
3-mo 0.99%
6-mo 5.06%
1-year 67.59%
3-year 102.01%
5-year 166.84%
YTD 36.43%
2020 14.09%
2019 53.76%
2018 -25.13%
2017 26.58%
2016 48.46%

LMAT Dividends

Ex-Dividend Date Type Payout Amount Change
Loading, please wait...
View Full LMAT Dividend History

Continue Researching LMAT

Here are a few links from around the web to help you further your research on Lemaitre Vascular Inc's stock as an investment opportunity:

Lemaitre Vascular Inc (LMAT) Stock Price | Nasdaq
Lemaitre Vascular Inc (LMAT) Stock Quote, History and News - Yahoo Finance
Lemaitre Vascular Inc (LMAT) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.8269 seconds.